P35222 (CTNB1_HUMAN) Homo sapiens (Human)
Catenin beta-1 UniProtKBInterProSTRINGInteractive Modelling
781 aa; Sequence (Fasta) ;
30 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF THE XTCF3-CBD/BETA-CATENIN ARMADILLO REPEAT COMPLEX |
Heteromer P70062; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BETA-CATENIN AND HTCF-4 |
Heteromer Q9NQB0; | |||||
| Assess | ||||||
| Beta-catenin binding domain of Axin in complex with beta-catenin |
Heteromer Q9YGY0; | |||||
| Assess | ||||||
| Crystal Structure of a beta-catenin/BCL9/Tcf4 complex |
Heteromer O00512; Q9NQB0; | |||||
| Assess | ||||||
| Crystal structure of beta-catenin in complex with cyclic peptide inhibitor |
Heteromer P09803; | 1×EPE; 1×CL; | ||||
| Assess | ||||||
| Beta-catenin in complex with a phosphorylated APC 20aa repeat fragment |
Heteromer P25054; | |||||
| Assess | ||||||
| Crystal structure of beta-catenin/ICAT helical domain/unphosphorylated APC R3 |
Heteromer P25054; Q9NSA3; | |||||
| Assess | ||||||
| Crystal structure of beta-catenin and the MDM2 p53-binding domain in complex with H332, a Helicon P… |
Heteromer Q00987; | 1×WHL; | ||||
| Assess | ||||||
| Crystal structure of beta-catenin and the MDM2 p53-binding domain in complex with H333, a Helicon P… |
Heteromer Q00987; | 1×WHL; | ||||
| Assess | ||||||
| Crystal structure of beta-catenin and the MDM2 p53-binding domain in complex with H330, a Helicon P… |
Heteromer Q00987; | 1×WHL; | ||||
| Assess | ||||||
| Beta-Catenin in complex with peptide 301 |
Heteromer O00512; | 3×PRO; | ||||
| Assess | ||||||
| Crystal Structure of the Beta-catenin/ICAT Complex |
Heteromer Q9JJN6; | |||||
| Assess | ||||||
| Crystal structure of LRH-1/beta-catenin complex |
Heteromer O00482; | 1×P6L; | ||||
| Assess | ||||||
| Crystal Structure of a Human Tcf-4 / beta-Catenin Complex |
Heteromer Q9NQB0; | |||||
| Assess | ||||||
| Crystal structure of beta-catenin and the MDM2 p53-binding domain in complex with H329, a Helicon P… |
Heteromer Q00987; | 1×WHL; | ||||
| Assess | ||||||
| X-ray structure of Beta catenin in complex with Bcl9 |
Heteromer O00512; | 4×EDO; 2×PEG; 2×IMD; | ||||
| Assess | ||||||
| Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-1933 ternary complex |
Heteromer P63208; Q9Y297; | 1×J8Y; 1×PO4; | ||||
| Assess | ||||||
| Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specifici… |
Heteromer P63208; Q9Y297; | |||||
| Assess | ||||||
| Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… |
Heteromer P04439; P61769; | 6×CD; 2×MG; 2×GOL; | ||||
| Assess | ||||||
| Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… |
Heteromer P04439; P61769; | 3×GOL; 2×MG; 6×CD; | ||||
| Assess | ||||||
| Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-2776 ternary complex |
Heteromer P63208; Q9Y297; | 2×J91; 1×PO4; | ||||
| Assess | ||||||
| Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-2663 ternary complex |
Heteromer P63208; Q9Y297; | 1×J8V; 1×PO4; | ||||
| Assess | ||||||
| Monophosphorylated pSer33 b-Catenin peptide, b-TrCP/Skp1, NRX-103094 ternary complex |
Heteromer P63208; Q9Y297; | 1×J97; 1×PO4; 1×CL; | ||||
| Assess | ||||||
| c-terminal beta-catenin bound TIP-1 structure |
Heteromer Q9DBG9; | |||||
| Assess | ||||||
| Crystal structure of HLA-A3*01 in complex with a wild-type beta-catenin peptide |
Heteromer P04439; P61769; | 2×PG4; 3×MES; 2×IMD; 4×PEG; 7×EDO; | ||||
| Assess | ||||||
| Crystal structure of HLA-A3*01 in complex with a mutant beta-catenin peptide |
Heteromer P04439; P61769; | 2×MES; 10×SO4; 2×PEG; | ||||
| Assess | ||||||
| FBXW11-SKP1 in complex with a pSer33/pSer37 Beta-Catenin peptide |
Heteromer P63208; Q9UKB1; | 4×GOL; 1×NA; | ||||
| Assess | ||||||
| Monophosphorylated pSer33 b-Catenin peptide bound to b-TrCP/Skp1 Complex |
Heteromer P63208; Q9Y297; | 1×PO4; 1×DMS; | ||||
| Assess | ||||||
| PAK4 kinase domain in complex with beta-catenin Ser675 substrate peptide |
Heteromer O96013; | |||||
| Assess | ||||||
| Crystal Structure of Beta-Catenin Armadillo Repeat Region and Its C-Terminal domain | monomer | |||||
| Assess | ||||||
| Beta-catenin Crystal Structure | monomer | |||||
| Assess | ||||||
| Human beta-catenin crystal structure | monomer | |||||
| Assess | ||||||
| Crystal structure of Beta-catenin Armadillo repeats domain in complex with the inhibitor RS6452 | monomer | 1×JKI; | ||||
| Assess | ||||||
| Structure of beta-catenin in complex with a stapled peptide inhibitor | monomer | |||||
| Assess | ||||||
| Structure of beta-catenin in complex with FP01567, a Helicon Polypeptide | monomer | 1×PO4; 6×GOL; 1×WHL; | ||||
| Assess | ||||||
| Structure of beta-catenin in complex with FP05874, a Helicon Polypeptide | monomer | 1×WHL; | ||||
| Assess | ||||||
| X-ray structure of first four repeats of human beta-catenin | monomer | 4×GOL; | ||||
| Assess | ||||||
| Beta-Catenin in complex with compound 6 | monomer | 1×R9Q; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2z6g.1.A | monomer | 0.83 | 97.18 | |||
| Assess | ||||||